2 ms·

Opposite.

• neuronic 2y ago
  Of course it is for therapeutics design, it's the literal last sentence of the abstract: "In conclusion, NTD-RBD bsAbs offer promising potential for the design of resilient, next-generation antibody therapeutics against SARS-CoV-2 VOCs."